Talasaz Amirali sells $39.3M of GHTalasaz Amirali 内部减持 GH $39.3M
Core Transaction Details
Co-Chief Executive Officer and Director Talasaz AmirAli completed an open-market sale of 260,000 common shares of Guardant Health (ticker GH) on June 29, 2026, with a total transaction value of ~$39,312,654. The trade was filed with the U.S. SEC via a Form 4 on June 30, 2026. This sale represents 0.198% of GH’s $19.9B current market cap, making it a mid-sized open-market trade from a company executive.
Market Signal & Cross-Check
As a core executive, Talasaz AmirAli’s sale size exceeds most recent GH open-market trades. Multiple GH Form 4 filings on June 30, 2026 show the executive completed additional trades that day: multiple open-market sales at $150-$152 per share, plus M-exempt trades of 143,028 and 111,804 shares at $4.18/share, with total open-market proceeds over $39M. Separately, as of June 1, 2026, GH’s analyst ratings were 5 strong buys, 18 buys, 1 hold, 1 sell, with overwhelmingly bullish sentiment.
What to Watch Next & Signal Limitations
This Form 4 disclosure only documents the completed open-market sale, and does not confirm if the trade was under a pre-arranged 10b5-1 plan, nor does it allow inference of the executive’s motivation or future stock price impact. Market participants should monitor subsequent SEC insider filings from Talasaz AmirAli, plus GH’s Q2 2026 earnings report due July 29, 2026.
核心交易详情
联合首席执行官兼董事Talasaz AmirAli于2026年6月29日完成Guardant Health（股票代码GH）260,000股普通股的公开市场出售，交易总价值约39,312,654美元，该交易于次日通过Form 4文件向美国SEC备案。该笔出售占GH当前199亿美元市值的0.198%，属于高管层面的中等规模场内交易。
市场信号与交叉验证
作为公司核心高管，Talasaz AmirAli的本次出售规模远超GH近期多数小额公开市场交易。2026年6月30日提交的多份GH Form 4文件显示，该高管当日还完成多笔额外交易：包括150至152美元每股的多笔公开市场出售，以及143,028股、111,804股的M类豁免交易（每股4.18美元），当日累计公开市场出售总金额超3900万美元。此外，截至2026年6月1日的分析师评级显示，GH获5份强力买入、18份买入、1份持有及1份卖出评级，看多情绪占绝对多数。
后续关注与信号局限
本次Form 4披露仅记录已完成的公开市场出售，无法确认该交易是否基于10b5-1预先安排计划，也无法推断高管动机或未来股价影响。后续可关注该高管后续SEC内幕交易披露文件，以及GH2026年7月29日发布的2026年第二季度财报。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。